Bayer Might Still Face Suit From Taiwan Patients Over Alleged HIV-tainted Blood Products
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Taiwan plaintiffs are appealing a U.S. federal court ruling that they should file a suit that revolves around their infection from alleged HIV-tainted blood products sold by a Bayer affiliate back in Taiwan rather than in the United States
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)